AL amyloidosis with IgD-lambda monoclonal gammopathy and lambda-type Bence-Jones protein: successful treatment by autologous stem cell transplantation-Reference-Cited by-同舟云学术

AL amyloidosis with IgD-lambda monoclonal gammopathy and lambda-type Bence-Jones protein: successful treatment by autologous stem cell transplantation

Published:2010-07-15 Issue:5 Volume:14 Page:506-510
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Sakurai-Chin Chanhyok,Ubara Yoshifumi,Suwabe Tatsuya,Hoshino Junichi,Yonaha Tomoki,Hasegawa Eiko,Sumida Keiichi,Hiramatsu Rikako,Yamanouchi Masayuki,Hayami Noriko,Yamauchi Junji,Tominaga Naoyuki,Sawa Naoki,Takemoto Fumi,Masuoka Kazuhiro,Takaichi Kenmei,Oohashi Kenichi

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Nephrology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10157-010-0311-2.pdf

Reference26 articles.

1. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997;337:898–909.

2. Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine (Baltimore). 1975;54:271–99.

3. Sanchorawala V, Wright DG, Seldin DC, Dember LM, Finn K, Falk RH, et al. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transpl. 2001;28:637–42.

4. Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med. 2004;140:85–93.

5. Perz JB, Schonland SO, Hundemer M, Kristen AV, Dengler TJ, Zeier M, et al. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study. Br J Haematol. 2004;127:543–51.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Long-term Outcomes after VAD plus SCT Therapy in a Patient with AL Amyloidosis and Severe Factor X Deficiency;Internal Medicine;2018

2. AA-negative and Kappa-positive Amyloidosis in a Patient with Rheumatoid Arthritis;Internal Medicine;2016

3. Immunoglobulin D amyloidosis: a distinct entity;Blood;2012-01-05